glp 1 drugs and rheumatoid arthritis GLP-1 Medications Arthritis: What the 2025 Research Actually Shows Do GLP-1 Help With Rheumatoid

Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care

A look at lapsed users shows that three-fifths (61%) of individuals previously using GLP-1 drugs for weight loss discontinued within six months, with a third (33%) lapsing in three months or less

Restrictive cardiomyopathy: definition and diagnosis

Disclaimer: This blog is for informational purposes only and does not substitute professional medical advice

Furthermore, the increasing awareness of the cardiovascular and renal benefits of GLP-1 receptor agonists is further driving their uptake in the region